.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Adult Immune Thrombocytopenia Purpura

EP. 1: Adult ITP: Causes and Pathophysiology

January 27th 2020

EP. 2: Risks of Bleeding and Thrombosis in Adult ITP

January 27th 2020

EP. 3: Tests to Aid in the Diagnosis of Adult ITP

January 27th 2020

EP. 4: Adult ITP: When Is It Appropriate to Initiate Therapy?

January 27th 2020

EP. 5: Frontline Corticosteroid Strategies in Adult ITP

January 27th 2020

EP. 6: 2019 ASH Guideline Update on Treating Relapsed/Refractory ITP

January 27th 2020

EP. 7: Targeting Syk in Adult Immune Thrombocytopenic Purpura

January 27th 2020

EP. 8: Syk Inhibition in Adult ITP: The FIT1 and FIT2 Trials

January 27th 2020

EP. 9: Adult Immune Thrombocytopenic Purpura: TPO Receptor Agonists

January 27th 2020

EP. 10: Rituximab or Platelet Transfusion in ITP

January 27th 2020

EP. 11: Later-Line Treatment Options in Adult ITP

January 27th 2020

EP. 12: Adult ITP: Promising Therapeutic Agents in Development

January 27th 2020

EP. 13: Use of Splenectomy in Adult Immune Thrombocytopenic Purpura

January 27th 2020